Effects of adenosine on adhesion molecule expression and cytokine production in human PBMC depend on the receptor subtype activated

H. K. Takahashi, H. Iwagaki, R. Hamano, Hidenori Wake, T. Kanke, K. Liu, Tadashi Yoshino, N. Tanaka, Masahiro Nishibori

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Background and purpose: Adenosine suppresses immune responses through adenosine 2A (A 2A) receptors, by raising intracellular cAMP. Interleukin (IL)-18 up-regulates the expression of intercellular adhesion molecule (ICAM)-1 on monocytes, leading to production of pro-inflammatory cytokines such as IL-12, interferon (IFN)-γ and tumor necrosis factor (TNF)-α by human peripheral blood mononuclear cells (PBMC). We have previously demonstrated that elevation of cAMP inhibits this IL-18-induced expression of adhesion molecules. In the present study, we examined the effect of adenosine on the IL-18-induced up-regulation of ICAM-1 on human monocytes and production of IL-12, IFN-γ and TNF-α by PBMC. Experimental approach: The expression of ICAM-1 was examined by flow cytometry. IL-12, IFN-γ and TNF-α were determined by ELISA ass1ay. Key results: Adenosine inhibited the IL-18-induced up-regulation of ICAM-1 on human monocytes and it abolished the IL-18-enhanced production of IL-12, IFN-γ and TNF-α. While an A 2A receptor antagonist reversed the action of adenosine, an A 1 or A 3 receptor antagonist enhanced them. An A 2A receptor agonist, CGS21680, mimicked the effects of adenosine and its effects were abolished not only by the A 2A receptor antagonist but also by A 1 or A 3 receptor agonists. Activation via A 2A receptors resulted in elevation of cAMP in monocytes, whereas the stimulation of A 1 or A 3 receptors inhibited it, suggesting that intracellular signal transduction following ligation of A 2A receptors might be blocked by activation of A 1 or A 3 receptors. Conclusions and Implications: Adenosine differentially regulates IL-18-induced adhesion molecule expression and cytokine production through several subtypes of its receptors.

Original languageEnglish
Pages (from-to)816-822
Number of pages7
JournalBritish Journal of Pharmacology
Volume150
Issue number6
DOIs
Publication statusPublished - Mar 18 2007

Fingerprint

Interleukin-18
Adenosine
Blood Cells
Intercellular Adhesion Molecule-1
Interleukin-12
Cytokines
Interferons
Purinergic P1 Receptors
Monocytes
Purinergic P1 Receptor Antagonists
Up-Regulation
Tumor Necrosis Factor-alpha
Purinergic P1 Receptor Agonists
Ligation
Signal Transduction
Flow Cytometry
Enzyme-Linked Immunosorbent Assay

Keywords

  • Adenosine
  • Cytokine
  • Human peripheral blood mononuclear cells
  • Intercellular adhesion molecule-1
  • Interleukin-18

ASJC Scopus subject areas

  • Pharmacology

Cite this

Effects of adenosine on adhesion molecule expression and cytokine production in human PBMC depend on the receptor subtype activated. / Takahashi, H. K.; Iwagaki, H.; Hamano, R.; Wake, Hidenori; Kanke, T.; Liu, K.; Yoshino, Tadashi; Tanaka, N.; Nishibori, Masahiro.

In: British Journal of Pharmacology, Vol. 150, No. 6, 18.03.2007, p. 816-822.

Research output: Contribution to journalArticle

@article{198e54e931cd4d7cbfff8e54338b6a19,
title = "Effects of adenosine on adhesion molecule expression and cytokine production in human PBMC depend on the receptor subtype activated",
abstract = "Background and purpose: Adenosine suppresses immune responses through adenosine 2A (A 2A) receptors, by raising intracellular cAMP. Interleukin (IL)-18 up-regulates the expression of intercellular adhesion molecule (ICAM)-1 on monocytes, leading to production of pro-inflammatory cytokines such as IL-12, interferon (IFN)-γ and tumor necrosis factor (TNF)-α by human peripheral blood mononuclear cells (PBMC). We have previously demonstrated that elevation of cAMP inhibits this IL-18-induced expression of adhesion molecules. In the present study, we examined the effect of adenosine on the IL-18-induced up-regulation of ICAM-1 on human monocytes and production of IL-12, IFN-γ and TNF-α by PBMC. Experimental approach: The expression of ICAM-1 was examined by flow cytometry. IL-12, IFN-γ and TNF-α were determined by ELISA ass1ay. Key results: Adenosine inhibited the IL-18-induced up-regulation of ICAM-1 on human monocytes and it abolished the IL-18-enhanced production of IL-12, IFN-γ and TNF-α. While an A 2A receptor antagonist reversed the action of adenosine, an A 1 or A 3 receptor antagonist enhanced them. An A 2A receptor agonist, CGS21680, mimicked the effects of adenosine and its effects were abolished not only by the A 2A receptor antagonist but also by A 1 or A 3 receptor agonists. Activation via A 2A receptors resulted in elevation of cAMP in monocytes, whereas the stimulation of A 1 or A 3 receptors inhibited it, suggesting that intracellular signal transduction following ligation of A 2A receptors might be blocked by activation of A 1 or A 3 receptors. Conclusions and Implications: Adenosine differentially regulates IL-18-induced adhesion molecule expression and cytokine production through several subtypes of its receptors.",
keywords = "Adenosine, Cytokine, Human peripheral blood mononuclear cells, Intercellular adhesion molecule-1, Interleukin-18",
author = "Takahashi, {H. K.} and H. Iwagaki and R. Hamano and Hidenori Wake and T. Kanke and K. Liu and Tadashi Yoshino and N. Tanaka and Masahiro Nishibori",
year = "2007",
month = "3",
day = "18",
doi = "10.1038/sj.bjp.0707126",
language = "English",
volume = "150",
pages = "816--822",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Effects of adenosine on adhesion molecule expression and cytokine production in human PBMC depend on the receptor subtype activated

AU - Takahashi, H. K.

AU - Iwagaki, H.

AU - Hamano, R.

AU - Wake, Hidenori

AU - Kanke, T.

AU - Liu, K.

AU - Yoshino, Tadashi

AU - Tanaka, N.

AU - Nishibori, Masahiro

PY - 2007/3/18

Y1 - 2007/3/18

N2 - Background and purpose: Adenosine suppresses immune responses through adenosine 2A (A 2A) receptors, by raising intracellular cAMP. Interleukin (IL)-18 up-regulates the expression of intercellular adhesion molecule (ICAM)-1 on monocytes, leading to production of pro-inflammatory cytokines such as IL-12, interferon (IFN)-γ and tumor necrosis factor (TNF)-α by human peripheral blood mononuclear cells (PBMC). We have previously demonstrated that elevation of cAMP inhibits this IL-18-induced expression of adhesion molecules. In the present study, we examined the effect of adenosine on the IL-18-induced up-regulation of ICAM-1 on human monocytes and production of IL-12, IFN-γ and TNF-α by PBMC. Experimental approach: The expression of ICAM-1 was examined by flow cytometry. IL-12, IFN-γ and TNF-α were determined by ELISA ass1ay. Key results: Adenosine inhibited the IL-18-induced up-regulation of ICAM-1 on human monocytes and it abolished the IL-18-enhanced production of IL-12, IFN-γ and TNF-α. While an A 2A receptor antagonist reversed the action of adenosine, an A 1 or A 3 receptor antagonist enhanced them. An A 2A receptor agonist, CGS21680, mimicked the effects of adenosine and its effects were abolished not only by the A 2A receptor antagonist but also by A 1 or A 3 receptor agonists. Activation via A 2A receptors resulted in elevation of cAMP in monocytes, whereas the stimulation of A 1 or A 3 receptors inhibited it, suggesting that intracellular signal transduction following ligation of A 2A receptors might be blocked by activation of A 1 or A 3 receptors. Conclusions and Implications: Adenosine differentially regulates IL-18-induced adhesion molecule expression and cytokine production through several subtypes of its receptors.

AB - Background and purpose: Adenosine suppresses immune responses through adenosine 2A (A 2A) receptors, by raising intracellular cAMP. Interleukin (IL)-18 up-regulates the expression of intercellular adhesion molecule (ICAM)-1 on monocytes, leading to production of pro-inflammatory cytokines such as IL-12, interferon (IFN)-γ and tumor necrosis factor (TNF)-α by human peripheral blood mononuclear cells (PBMC). We have previously demonstrated that elevation of cAMP inhibits this IL-18-induced expression of adhesion molecules. In the present study, we examined the effect of adenosine on the IL-18-induced up-regulation of ICAM-1 on human monocytes and production of IL-12, IFN-γ and TNF-α by PBMC. Experimental approach: The expression of ICAM-1 was examined by flow cytometry. IL-12, IFN-γ and TNF-α were determined by ELISA ass1ay. Key results: Adenosine inhibited the IL-18-induced up-regulation of ICAM-1 on human monocytes and it abolished the IL-18-enhanced production of IL-12, IFN-γ and TNF-α. While an A 2A receptor antagonist reversed the action of adenosine, an A 1 or A 3 receptor antagonist enhanced them. An A 2A receptor agonist, CGS21680, mimicked the effects of adenosine and its effects were abolished not only by the A 2A receptor antagonist but also by A 1 or A 3 receptor agonists. Activation via A 2A receptors resulted in elevation of cAMP in monocytes, whereas the stimulation of A 1 or A 3 receptors inhibited it, suggesting that intracellular signal transduction following ligation of A 2A receptors might be blocked by activation of A 1 or A 3 receptors. Conclusions and Implications: Adenosine differentially regulates IL-18-induced adhesion molecule expression and cytokine production through several subtypes of its receptors.

KW - Adenosine

KW - Cytokine

KW - Human peripheral blood mononuclear cells

KW - Intercellular adhesion molecule-1

KW - Interleukin-18

UR - http://www.scopus.com/inward/record.url?scp=33947324677&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947324677&partnerID=8YFLogxK

U2 - 10.1038/sj.bjp.0707126

DO - 10.1038/sj.bjp.0707126

M3 - Article

C2 - 17310143

AN - SCOPUS:33947324677

VL - 150

SP - 816

EP - 822

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 6

ER -